Reactivation of Pulmonary Tuberculosis in a Patient With Rheumatoid Arthritis During Treatment With IL-1 Receptor Antagonists (Anakinra)
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Rheumatology
Reference8 articles.
1. Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases.;Furst;Ann Rheum Dis,2005
2. Update on tuberculosis and other opportunistic infections associated with drugs blocking tumour necrosis factor α.;Winthrop;Ann Rheum Dis,2005
3. Safety of tumour necrosis factor and interleukin-1 blocking agents in rheumatic diseases.;Botsios;Autoimmun Rev,2005
4. Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-agents.;Fleishmann;Clin Exp Rheumatol,2002
5. TNF-blocking agents and tuberculosis: new drugs illuminate an old topic.;Keane;Rheumatology,2005
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immunosuppression is a conserved driver of tuberculosis susceptibility;2023-11-01
2. Secondary immunodeficiencies and infectious considerations of biologic immunomodulatory therapies;Annals of Allergy, Asthma & Immunology;2023-06
3. Evaluation of Tuberculosis Risk under Interleukin-1 Inhibitor Agents in Patients with Autoinflammatory Diseases: Experience from a Region with Moderate Tuberculosis Prevalence;Aktuelle Rheumatologie;2023-03-15
4. Role of theranostics in targeting inflammation in chronic diseases;Recent Developments in Anti-Inflammatory Therapy;2023
5. Host‐directed anti‐mycobacterial activity of colchicine, an anti‐gout drug, via strengthened host innate resistance reinforced by the IL‐1β/PGE 2 axis;British Journal of Pharmacology;2022-04-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3